Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
PremiumPress ReleasesAptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
19d ago
Aptose Biosciences Issues Non-Official Financial Update
Premium
Company Announcements
Aptose Biosciences Issues Non-Official Financial Update
1M ago
Aptose Announces Adjournment of its Special Meeting of Shareholders
Premium
Press Releases
Aptose Announces Adjournment of its Special Meeting of Shareholders
1M ago
Aptose Biosciences Faces Nasdaq Delisting Challenge
PremiumCompany AnnouncementsAptose Biosciences Faces Nasdaq Delisting Challenge
2M ago
Aptose Announces Receipt of Deficiency Notice from Nasdaq
Premium
Press Releases
Aptose Announces Receipt of Deficiency Notice from Nasdaq
2M ago
Aptose Biosciences Shareholders Approve Key Proposals
Premium
Company Announcements
Aptose Biosciences Shareholders Approve Key Proposals
3M ago
Aptose Biosciences price target lowered to $7 from $23 at H.C. Wainwright
PremiumThe FlyAptose Biosciences price target lowered to $7 from $23 at H.C. Wainwright
3M ago
Aptose Biosciences Secures $4.43 Million Funding
Premium
Company Announcements
Aptose Biosciences Secures $4.43 Million Funding
4M ago
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Premium
Press Releases
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100